• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体诱导的CD26表面表达调节。

Antibody-induced modulation of CD26 surface expression.

作者信息

Mattern T, Reich C, Duchrow M, Ansorge S, Ulmer A J, Flad H D

机构信息

Forschungsinstitut Borstel, Department of Immunology and Cell Biology, Borstel, Germany.

出版信息

Immunology. 1995 Apr;84(4):595-600.

PMID:7790033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1415157/
Abstract

The ability of different anti-CD26 monoclonal antibodies to modulate the expression of CD26 on human T lymphocytes was investigated. By means of a new non-radioactive method using fluorescein isothiocyanate (FITC)-labelled and unlabelled anti-CD26 monoclonal antibodies and flow cytometry, we measured the internalization and re-expression of CD26 on freshly isolated resting human T lymphocytes. The modulation of CD26 surface expression takes place in primarily CD26+ as well as in CD26- T lymphocytes, indicating the presence of an intracellular CD26 pool. In fact, with two different anti-CD26 monoclonal antibodies (Ta1 and M5) intracellular CD26 was detected out of which newly expressed CD26 might have originated. This intracellular CD26 pool appears to be maintained by continuous translation of CD26 mRNA.

摘要

研究了不同抗CD26单克隆抗体调节人T淋巴细胞上CD26表达的能力。通过一种新的非放射性方法,使用异硫氰酸荧光素(FITC)标记和未标记的抗CD26单克隆抗体以及流式细胞术,我们测量了新鲜分离的静息人T淋巴细胞上CD26的内化和重新表达。CD26表面表达的调节主要发生在CD26 +以及CD26 - T淋巴细胞中,表明存在细胞内CD26池。事实上,用两种不同的抗CD26单克隆抗体(Ta1和M5)检测到了细胞内CD26,新表达的CD26可能由此产生。这个细胞内CD26池似乎通过CD26 mRNA的持续翻译得以维持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd7/1415157/90d5b2080a65/immunology00074-0101-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd7/1415157/90d5b2080a65/immunology00074-0101-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd7/1415157/90d5b2080a65/immunology00074-0101-a.jpg

相似文献

1
Antibody-induced modulation of CD26 surface expression.抗体诱导的CD26表面表达调节。
Immunology. 1995 Apr;84(4):595-600.
2
Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.脊髓T淋巴细胞的激活。IV. 1F7(CD26)分子的表面表达及功能作用分析。
Cell Immunol. 1994 Apr 15;155(1):205-18. doi: 10.1006/cimm.1994.1113.
3
Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia.B 慢性淋巴细胞白血病患者外周血 B 淋巴细胞上 CD26/二肽基肽酶 IV 的组成性表达
Br J Cancer. 1999 Mar;79(7-8):1042-8. doi: 10.1038/sj.bjc.6690167.
4
Purified and cell-bound CD26: enzymatic inhibition, antibody binding profile, and expression on T cells in relation to other surface markers.纯化的和细胞结合的CD26:酶抑制、抗体结合谱以及与其他表面标志物相关的T细胞上的表达。
Verh K Acad Geneeskd Belg. 1994;56(6):537-59.
5
Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes.CD26/二肽基肽酶IV对人活化淋巴细胞的细胞因子依赖性调节机制
Cytokine. 2000 Jul;12(7):1136-41. doi: 10.1006/cyto.1999.0643.
6
Molecular characterization of bovine CD26 upregulated by a staphylococcal superantigen.由葡萄球菌超抗原上调的牛CD26的分子特征
Immunogenetics. 2002 Jun;54(3):216-20. doi: 10.1007/s00251-002-0456-6. Epub 2002 Apr 20.
7
Cytokines regulate membrane adenosine deaminase on human activated lymphocytes.细胞因子调节人活化淋巴细胞上的膜腺苷脱氨酶。
J Leukoc Biol. 2001 Dec;70(6):920-30.
8
A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals.一种由CD26控制的细胞表面级联反应,用于调节T细胞运动和趋化因子信号。
J Immunol. 2009 Sep 15;183(6):3616-24. doi: 10.4049/jimmunol.0804336. Epub 2009 Aug 17.
9
Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.人源化抗CD26单克隆抗体治疗恶性间皮瘤肿瘤。
Clin Cancer Res. 2007 Jul 15;13(14):4191-200. doi: 10.1158/1078-0432.CCR-07-0110.
10
Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.二肽基肽酶IV(CD26,Tp103)在转染的人T细胞中的功能
Cell Immunol. 1993 Feb;146(2):249-60. doi: 10.1006/cimm.1993.1024.

引用本文的文献

1
Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy.可溶性CD26:从癌症诊断的潜在生物标志物到免疫治疗动态监测的可信标志物
Cancers (Basel). 2024 Jun 30;16(13):2427. doi: 10.3390/cancers16132427.
2
Intra- and Extracellular Effector Vesicles From Human T And NK Cells: Same-Same, but Different?人 T 细胞和 NK 细胞的细胞内和细胞外效应囊泡:似曾相识,却又不同?
Front Immunol. 2021 Dec 23;12:804895. doi: 10.3389/fimmu.2021.804895. eCollection 2021.
3
The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells.

本文引用的文献

1
Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity.己酮可可碱:白细胞介素-2和γ-干扰素生物合成以及卡介苗诱导的细胞毒性的强效抑制剂。
Immunology. 1993 Sep;80(1):151-6.
2
Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle.抗CD26单克隆抗体可使人类T淋巴细胞在细胞周期的G1期晚期发生可逆性停滞。
Immunobiology. 1993 Jun;188(1-2):36-50. doi: 10.1016/S0171-2985(11)80485-7.
3
Oligosaccharide reprocessing and recycling of a cell surface glycoprotein in cultured rat hepatocytes.
非转化和恶性T细胞中的丝氨酸蛋白酶CD26/DPP4
Cancers (Basel). 2021 Nov 26;13(23):5947. doi: 10.3390/cancers13235947.
4
Distinctive CD26 Expression on CD4 T-Cell Subsets.CD4 T 细胞亚群上独特的 CD26 表达。
Biomolecules. 2021 Oct 2;11(10):1446. doi: 10.3390/biom11101446.
5
Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4.人细胞毒性淋巴细胞的脱粒是蛋白水解活性可溶性 CD26/DPP4 的主要来源。
Cell Mol Life Sci. 2020 Feb;77(4):751-764. doi: 10.1007/s00018-019-03207-0. Epub 2019 Jul 12.
6
CD26 and Asthma: a Comprehensive Review.CD26 与哮喘:全面综述。
Clin Rev Allergy Immunol. 2019 Apr;56(2):139-160. doi: 10.1007/s12016-016-8578-z.
7
Dipeptidyl peptidase-4 and kidney fibrosis in diabetes.二肽基肽酶-4与糖尿病肾病纤维化
Fibrogenesis Tissue Repair. 2016 Feb 13;9:1. doi: 10.1186/s13069-016-0038-0. eCollection 2016.
8
DPP4 in Diabetes.糖尿病中的二肽基肽酶4
Front Immunol. 2015 Jul 27;6:386. doi: 10.3389/fimmu.2015.00386. eCollection 2015.
9
Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.二肽基肽酶-4抑制剂的药理学、生理学及作用机制
Endocr Rev. 2014 Dec;35(6):992-1019. doi: 10.1210/er.2014-1035. Epub 2014 Sep 12.
10
On the origin of serum CD26 and its altered concentration in cancer patients.血清CD26的起源及其在癌症患者中浓度的改变
Cancer Immunol Immunother. 2009 Nov;58(11):1723-47. doi: 10.1007/s00262-009-0728-1. Epub 2009 Jun 26.
培养的大鼠肝细胞中细胞表面糖蛋白的寡糖再加工与循环利用
Biol Chem Hoppe Seyler. 1993 Apr;374(4):255-63. doi: 10.1515/bchm3.1993.374.1-6.255.
4
A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.一种人类黑素细胞肿瘤进展的标志物是一种细胞表面外肽酶。
J Exp Med. 1993 Apr 1;177(4):1135-43. doi: 10.1084/jem.177.4.1135.
5
Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.二肽基肽酶IV(CD26,Tp103)在转染的人T细胞中的功能
Cell Immunol. 1993 Feb;146(2):249-60. doi: 10.1006/cimm.1993.1024.
6
T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells.T细胞活化抗原CD26作为HIV进入CD4+细胞的辅助因子。
Science. 1993 Dec 24;262(5142):2045-50. doi: 10.1126/science.7903479.
7
Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production.人淋巴细胞上的二肽基肽酶IV(CD26)。二肽基肽酶IV的合成抑制剂和抗体可抑制商陆有丝分裂原刺激的外周血单个核细胞的增殖以及白细胞介素-2和白细胞介素-6的产生。
Immunobiology. 1993 Aug;188(4-5):403-14. doi: 10.1016/S0171-2985(11)80223-8.
8
OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.OKT3:一种具有强大促有丝分裂特性的单克隆抗人T淋巴细胞抗体。
J Immunol. 1980 Jun;124(6):2708-13.
9
Different half-lives of the carbohydrate and protein moieties of a 110,000-dalton glycoprotein isolated from plasma membranes of rat liver.从大鼠肝脏质膜分离出的一种110,000道尔顿糖蛋白的碳水化合物和蛋白质部分的不同半衰期。
Proc Natl Acad Sci U S A. 1980 Apr;77(4):1828-31. doi: 10.1073/pnas.77.4.1828.
10
Heterogeneous turnover of terminal and core sugars within the carbohydrate chain of dipeptidylaminopeptidase IV isolated from rat liver plasma membrane.从大鼠肝细胞膜分离的二肽基氨基肽酶IV碳水化合物链中末端糖和核心糖的异质性周转。
FEBS Lett. 1983 Oct 31;163(1):150-2. doi: 10.1016/0014-5793(83)81183-1.